Published in Am Rev Respir Dis on March 01, 1979
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Measurement of bronchial reactivity: a question of interpretation. Thorax (1981) 1.25
Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach. J Occup Med Toxicol (2012) 1.04
Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax (1987) 0.94
Compensating occupational asthma. Thorax (1981) 0.92
Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J (1979) 0.89
Factors relating to the development of respiratory symptoms in coffee process workers. Br J Ind Med (1991) 0.89
Occupational asthma. West J Med (1982) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Computer-based interview for screening blood donors for risk of HIV transmission. JAMA (1992) 4.01
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
Guidelines for management of HIV infection with computer-based patient's record. Lancet (1995) 2.91
Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest (1995) 2.47
Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis. J Gen Intern Med (1992) 2.07
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
Methacholine challenge: test-shortening procedures. Chest (2001) 2.00
Chronic bronchitis and decreased forced expiratory flow rates in lifetime nonsmoking grain workers. Am Rev Respir Dis (1980) 1.86
Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol (1987) 1.78
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med (1994) 1.66
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest (1996) 1.65
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Mechanism of perennial allergic asthma. Lancet (1983) 1.58
Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol (1998) 1.58
Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis (1980) 1.57
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Methacholine PC20 extrapolation. Chest (1998) 1.50
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr (2000) 1.45
Right-sided aortic arch presenting as refractory intraoperative and postoperative wheezing. Chest (1991) 1.45
Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J (2009) 1.45
Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest (1983) 1.44
Indirect airway challenges. Eur Respir J (2003) 1.42
Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol (1987) 1.31
Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol (1995) 1.25
Pulmonary diffusing capacity measured at multiple intervals during a single exhalation in man. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.21
Effects of grain dust exposure and smoking on respiratory symptoms and lung function. J Occup Med (1983) 1.21
Calcitonin from ultimobranchial glands of dogfish and chickens. Science (1967) 1.20
Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis (1987) 1.16
Effects of smoking and occupational exposure on peripheral airway function in young cereal grain workers. Am Rev Respir Dis (1982) 1.13
Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax (1983) 1.13
Ultimobranchial origin of calcitonin. Hypocalcemic effect of extracts from chicken glands. Can J Physiol Pharmacol (1967) 1.12
Factors in allergen-induced asthma: relevance of the intensity of the airways allergic reaction and non-specific bronchial reactivity. Clin Allergy (1976) 1.11
Increased bronchial reactivity to inhaled histamine in nonsmoking grain workers with normal lung function. Chest (1980) 1.08
Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis (1984) 1.08
Asthma caused by occupational exposure to a furan-based binder system. J Allergy Clin Immunol (1980) 1.08
Miliary tuberculosis presenting with hyponatremia and thrombocytopenia. Can Med Assoc J (1976) 1.07
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J (1993) 1.06
Determination of histamine PC20. Comparison of linear and logarithmic interpolation. Chest (1983) 1.05
Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air (2008) 1.05
Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol (2004) 1.05
Bronchial response to inhaled histamine in asymptomatic young smokers. Eur J Respir Dis (1983) 1.02
Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered (1990) 1.01
Grain dust and health. III. Environmental factors. Ann Intern Med (1978) 1.00
The beta-agonist controversy. Med Clin North Am (1996) 1.00
Computer interview for screening blood donors for risk of HIV transmission. MD Comput (1994) 1.00
Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr (1991) 1.00
Cardiovascular abnormalities in the Marfanoid hypermobility syndrome. Arthritis Rheum (1976) 0.99
Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis (1992) 0.99
The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy (2007) 0.98
Cigarette smoking, airway hyperresponsiveness, and asthma. Chest (1988) 0.97
Out-patient management of bronchial asthma. Can Fam Physician (1989) 0.96
Asthma management in the emergency department. Can Respir J (2000) 0.96
A clinical trial of a knowledge-based medical record. Medinfo (1995) 0.96
Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol (2000) 0.96
Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine. Thorax (1983) 0.96
Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax (1987) 0.94
Volume adjustment of maximal midexpiratory flow. Importance of changes in total lung capacity. Chest (1980) 0.94
Decrease in non-specific bronchial reactivity in an asthmatic following treatment of hyperthyroidism. Ann Allergy (1978) 0.93
Characteristics of airway tone during exercise in patients with asthma. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.92
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med (1999) 0.92
Standardization of inhalation provocation tests. Dose vs concentration of histamine. Chest (1982) 0.91
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol (1997) 0.91
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Occupational asthma caused by cedar urea formaldehyde particle board. Chest (1982) 0.90
Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol (1977) 0.90
Self-injection with olive oil. A cause of lipoid pneumonia. Chest (1995) 0.90
Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J (1979) 0.89
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J (1998) 0.89
Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J (1981) 0.89
Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol (1996) 0.89
Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection. Chest (2001) 0.89
Effect of Sch1000 in allergen-induced asthma. Clin Allergy (1978) 0.88
Effect of thoracic displacement and vagotomy on the canine gastresophageal junctional zone. Gastroenterology (1969) 0.88
Chronic bronchitis and exposure to cereal grain dust. Am Rev Respir Dis (1979) 0.88
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
Pulmonary function in Pi M and MZ grainworkers. Chest (1986) 0.87
How best to measure airway responsiveness. Am J Respir Crit Care Med (2001) 0.87
Correlation of bronchial responsiveness to diluent and to histamine. Ann Allergy (1982) 0.87
Rapid, shallow breathing after Ascaris suum antigen inhalation: role of vagus nerves. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.86
The mechanism of rapid, shallow breathing after inhaling histamine aerosol in exercising dogs. Am Rev Respir Dis (1976) 0.86
Respiratory health risks in farmers. Ann Intern Med (1981) 0.86